FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ENvue Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026
- Market cap
- $3.08M
- P/E (TTM)
- –
- Dividend yield
- –
ENvue Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Market Cap | $5.54M | $230.55M |
| Enterprise Value | $4.46M | $202.97M |
| PS Ratio | 2.88 | 3.10 |
| PB Ratio | 0.18 | 3.04 |
Enterprise value
| Measure | ENvue Medical | Industry median |
|---|---|---|
| EV / Sales | 2.31 | 2.91 |
Income (trailing twelve months)
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Revenue | $1.93M | $102.39M |
| Gross Profit | -$502.00K | $60.36M |
| Operating Income | -$26.25M | -$4.31M |
| Pretax Income | -$21.42M | -$2.37M |
| Net Income | -$21.06M | -$6.57M |
| EBITDA | -$25.30M | -$1.98M |
Margins
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Gross Margin | -26.1% | 55.2% |
| Operating Margin | -1362.7% | -6.04% |
| Pretax Margin | -1111.9% | -4.11% |
| Profit Margin | -1093.6% | -10.5% |
| EBITDA Margin | -1313.3% | -2.67% |
| FCF Margin | -609.8% | 0.02% |
Returns
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | -59.1% | -18.2% |
| Return on Assets (ROA) | -46.9% | -13.3% |
| Return on Invested Capital (ROIC) | -62.7% | -3.69% |
| Return on Capital Employed (ROCE) | -84.4% | -9.07% |
Growth
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -17.7% | 8.85% |
| Revenue Growth (3Y CAGR) | 50.3% | 7.08% |
| Revenue Growth (5Y CAGR) | 32.6% | 11.8% |
Balance sheet
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.08M | $36.66M |
| Net Cash (Debt) | $1.08M | $3.92M |
| Net Cash Per Share | $0.10 | $0.28 |
| Equity (Book Value) | $30.76M | $55.33M |
| Book Value Per Share | $2.77 | $2.87 |
| Tangible Book Value | -$2.29M | $10.79M |
| Working Capital | -$2.49M | $56.72M |
Financial position
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Current Ratio | 0.66 | 2.48 |
| Quick Ratio | 0.18 | 1.53 |
Cash flow (trailing twelve months)
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$11.65M | -$566.22K |
| Capital Expenditures | -$95.00K | -$3.69M |
| Free Cash Flow | -$11.74M | -$696.00K |
| FCF Per Share | -$1.06 | -$0.02 |
Efficiency
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.04 | 0.58 |
| Inventory Turnover | 1.01 | 2.21 |
| Revenue Per Employee | $275.14K | $322.92K |
| Profits Per Employee | -$3.01M | -$51.88K |
| Employee Count | 7 | 185 |
Dividends and yields
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Earnings Yield | -380.0% | -6.88% |
| FCF Yield | -211.9% | -0.45% |
Shares
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Shares Outstanding | 11,084,600 | 44,302,700 |
| Shares Change (QoQ) | 121.4% | 0.27% |
| Float | 10,679,700 | 37,462,700 |
| Shares Held by Insiders | 3.65% | 10.5% |
Taxes
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Income Tax | -$353.00K | $1.52M |
Scores
| Measure | ENvue Medical | Industry median |
|---|---|---|
| Altman Z-Score | -6.38 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | 6.65 | -2.64 |
Calculated by StockData from ENvue Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.